A year ago, Gil H. Choi stood in the Rockville laboratories of Human Genome Sciences Inc., nervously watching a group of white rats. Injected with synthetic anthrax spores an hour and a half earlier, the rats should have been dead. But there they were, scurrying around in a sealed glass case.
